[ad_1]
The goal is to make it available in Europe by the end of the year.
Pfizer and BioNTech have submitted their COVID-19 vaccine for emergency approval to the European Medicines Agency (EMA). Both companies said this in an announcement Tuesday.
The goal is to make the vaccine available in Europe by the end of the year, the DPA news agency wrote.
The American pharmaceutical giant Pfizer, in collaboration with the small German biotech company BioNTech, which specializes in new mRNA technology in the production of the vaccine, informed that the application was submitted on Monday and has also been officially confirmed.
Both companies joined the American company Moderna, which also asked the EU regulator for conditional approval of its COVID-19 vaccine on Monday.
Pfizer CEO Albert Bourla praised the application for approval as “another key milestone” in an effort to alleviate the health crisis, along with BioNTech.
Their vaccine was 95% effective against COVID-19 in clinical trials.
Like Moderna, BioNTech and Pfizer have also requested emergency approval from the US Food and Drug Administration (FDA).
[ad_2]
Source link
